Hi all,
I apologize if you have already received this action alert, but I'm hoping that
someone on here might want to participate.
EndHepCMA is looking for a clinician to speak on the potential benefit of
supervised consumption spaces on HCV prevention, care, linkage, and treatment?
This time needs to be specifically tailored to this topic.
I was going to do it but there are already several other BHCHP staff presenting
on HIV and overdose prevention so it would be wonderful to have another voice
in the mix.
The updated date is Sept 27th at 1pm (disregard the date below).
Is anyone possibly interested? If so, I will put you in touch with Rich Baker
at Victory Programs.
Maggie
Marguerite Beiser, ANP-BC
Director of HCV Services
Boston Health Care for the Homeless Program
780 Albany St.
Boston, MA 02118
Answering Service 781-221-6565
mbeiser@xxxxxxxxx<mailto:mbeiser@xxxxxxxxx>
________________________________
From: Rich Baker <rbaker@xxxxxxx>
Sent: Tuesday, August 31, 2021 10:20 AM
To: Beiser, Marguerite <mbeiser@xxxxxxxxx>
Subject: ACTION ALERT - SCS Bill Testimony
CAUTION: This email originated from outside of the organization. Do not click
links or open attachments unless you recognize the sender and know the content
is safe.
We need your help to bring Supervised Consumption Sites to MA!
[https://gallery.mailchimp.com/430c38bfdddf96bcab9022241/images/41b71ddd-45eb-4490-8e27-aaa982549177.png]
Supervised Consumption Sites Save Lives
Testify in Support!
Have you heard the good news?
H.2088,<https://linkprotect.cudasvc.com/url?a=https%3a%2f%2fvpi.us16.list-manage.com%2ftrack%2fclick%3fu%3d430c38bfdddf96bcab9022241%26id%3de18110886a%26e%3d05c672ded4&c=E,1,oPgNr2pUUerKzOn7TbwnVvO3IzwulC_0MYdlR3q8EJ8uDIBJn8A6HUAZ8rp-qqM6Sg_B0SO_UBcFaKNLcHzBP2WxWoH0N3aOeY_nEPAMzGY,&typo=1>
S.1272<https://linkprotect.cudasvc.com/url?a=https%3a%2f%2fvpi.us16.list-manage.com%2ftrack%2fclick%3fu%3d430c38bfdddf96bcab9022241%26id%3de5f7c2daf9%26e%3d05c672ded4&c=E,1,olF_I2-MZMT6koxVPSTuq1kvZ3wautFu66TLcolN2-lpGj1DBEN5TFi7631groQGK9lHmGMnWgldWv89zTD1-_1QZcJ-m3j2zkr3WCtWcXU,&typo=1>
An Act relative to preventing overdose deaths and increasing access to
treatment, Aubri’s Law, has a public hearing date set for September 27th at 9am
in front of the Joint Committee on Mental Health, Substance Use and
Recovery.<https://linkprotect.cudasvc.com/url?a=https%3a%2f%2fvpi.us16.list-manage.com%2ftrack%2fclick%3fu%3d430c38bfdddf96bcab9022241%26id%3dd3348dbf44%26e%3d05c672ded4&c=E,1,La11ymiN6bumKx3nGEg2DS8S8QTgdBWuF3JfExIOs6fcclsUZKJPIWZ91sCelkdYSQ2UOTmFJbi294U_OXnH3TrxlVEP1RofedSaRPkYIwnXUDVxRADx&typo=1>
For more on the details of the bill and the benefits these programs will bring
to Massachusetts, check out the fact sheet created by our partner SIFMA Now!
We need your help for testimony! The EndHepCMA Coalition is seeking 3 more
individuals to provide oral testimony at the September 29 hearing. We are
seeking someone willing to speak to how these programs would be beneficial
through the lens of HCV prevention and treatment. We are looking for someone
with lived experience as well as a provider to discuss how SCS could help
support folks getting connected to HCV care and/or reducing transmission.
If you or someone you know is interested in testifying, please reach out to
Rich directly at rbaker@xxxxxxx.
SCS Fact
Sheet<https://linkprotect.cudasvc.com/url?a=https%3a%2f%2fvpi.us16.list-manage.com%2ftrack%2fclick%3fu%3d430c38bfdddf96bcab9022241%26id%3d1b5ad6fd2e%26e%3d05c672ded4&c=E,1,ZhX8oqk0vr1vBHFj6JQ2C5lYrYym0vmYeGS095Qt01OHjVLW0_BXE_TdqgN3gFJocIeqmpBnO8wcJMwMmzOlXaQpoklSMCHff5Vb1FxKfZoHN-I,&typo=1>
[Facebook]<https://linkprotect.cudasvc.com/url?a=https%3a%2f%2fvpi.us16.list-manage.com%2ftrack%2fclick%3fu%3d430c38bfdddf96bcab9022241%26id%3de57840134a%26e%3d05c672ded4&c=E,1,nt5hlo71SsxtzmTWRiXeCJlmp1LyrTnFGKulmRjXfXvWqTC4hi_wtXkX8CiclG-fVDkp27MDOTLiNJIk-MNJaI8rQOxs8FoLHmlicrkzoHgoiw4gIDDAR1SB&typo=1>
[Twitter]<https://linkprotect.cudasvc.com/url?a=https%3a%2f%2fvpi.us16.list-manage.com%2ftrack%2fclick%3fu%3d430c38bfdddf96bcab9022241%26id%3d94e9f5d6b2%26e%3d05c672ded4&c=E,1,787EnRPG3vJYWS9bwR6hERymoiSrsU8L1uqqnRBddAO5H901kcSTHbXR1Yq1zhgcLx6RyquBn1LnexKQItCQQw2g3T-PQJztasSPLAxqke1qVmmDSLYnZI9bOw,,&typo=1>
[Link]<https://linkprotect.cudasvc.com/url?a=https%3a%2f%2fvpi.us16.list-manage.com%2ftrack%2fclick%3fu%3d430c38bfdddf96bcab9022241%26id%3dca02235300%26e%3d05c672ded4&c=E,1,8kEPJER0ZOHLscca1kbV4eGbgda8PByVqEZPFhh3PLkeZ4xDRX9UL6Q6S7s0rA61d_PWSzYu5-rcsESIaVbqQcdd9NEpTaeZ8TapQMaG&typo=1>
[Website]<https://linkprotect.cudasvc.com/url?a=https%3a%2f%2fvpi.us16.list-manage.com%2ftrack%2fclick%3fu%3d430c38bfdddf96bcab9022241%26id%3d0ab30dcbed%26e%3d05c672ded4&c=E,1,mWyrLCdgZM6bqFAOKhoyumzPVsnmstkIj26BLUPAJSEoq8hxWl_S2i3Fi5LIPodz7C45lAnnPQJQCQOSEHyR5zv4T_h8P_sNj9jaO3inI4NO2MCb&typo=1>
Copyright © 2021 EndHepCMA, All rights reserved.
You are receiving this email because you opted in via our website.
Our mailing address is:
EndHepCMA
29 Stanhope Street
Boston, Ma 02116
Add us to your address
book<https://linkprotect.cudasvc.com/url?a=https%3a%2f%2fvpi.us16.list-manage.com%2fvcard%3fu%3d430c38bfdddf96bcab9022241%26id%3d5bf70b0d7b&c=E,1,-cshyNhsZicVCo4BbJk4fAsQB8m9W2NHexlnSqoa8NtdVVCFz479G3qM5SRN-Ki39fHHMN-e7AnZ4UtoVGb5RA_IrHsesVUqLKh6R5VMRBuNIbcgmw4,&typo=1>
Want to change how you receive these emails?
You can update your
preferences<https://linkprotect.cudasvc.com/url?a=https%3a%2f%2fvpi.us16.list-manage.com%2fprofile%3fu%3d430c38bfdddf96bcab9022241%26id%3d5bf70b0d7b%26e%3d05c672ded4%26c%3d7921f30683&c=E,1,RFpGySJqa_3XN1sFehhyLA50NRmyOoF47uEgIwAiMRCCR1afUwwCEMkPYWHSmI4IBbM1ddly5HA55Hs3NokagyGX4ajnjetllxxsfK8RMRX8CA,,&typo=1>
or unsubscribe from this
list<https://linkprotect.cudasvc.com/url?a=https%3a%2f%2fvpi.us16.list-manage.com%2funsubscribe%3fu%3d430c38bfdddf96bcab9022241%26id%3d5bf70b0d7b%26e%3d05c672ded4%26c%3d7921f30683&c=E,1,cCdRIcE60YGbWd12ZB_ffHKCTRR1pKXg5eJxG9zknRlPTh_pwpZmTM2T_uVIQyzfw0GI_If7rRGZDOb1xLZeLzeJ0_B8JbnTHWI-53Igll2nhNqkPZ2GvTp5B4Pa&typo=1>.
[Email Marketing Powered by
Mailchimp]<http://www.mailchimp.com/email-referral/?utm_source=freemium_newsletter&utm_medium=email&utm_campaign=referral_marketing&aid=430c38bfdddf96bcab9022241&afl=1>
The information transmitted is intended only for the person or entity to which
it is addressed and may contain confidential and/or privileged material. Any
review, retransmission, dissemination or other use of, or taking of any action
in reliance upon, this information by persons or entities other than the
intended recipient is prohibited. If you received this in error, please contact
the sender and delete the material from any computer.
